EcoDrugPlus

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSUPAG00010001940
Gene Symbol: SRD5A2
3 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSUPAG00010003568
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSUPAG00010017977
Gene Symbol: SI
3 Cross references
200 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSUPAG00010010396
Gene Symbol: SNCA
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSUPAG00010016322
Gene Symbol: TACR1
1 Cross references
267 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSUPAG00010008910
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSUPAG00010023888
Gene Symbol: TACR3
1 Cross references
256 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSUPAG00010011341
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSUPAG00010015595
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSUPAG00010008535
Gene Symbol: TBXA2R
1 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSUPAG00010006263
Gene Symbol: TYMP
1 Cross references
173 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSUPAG00010001450
Gene Symbol: THRB
1 Cross references
392 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).